Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction - Wikidata - awgldk - TriplyDB

Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction

Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction

http://www.wikidata.org/entity/Q34768018

about

Models of chronic obstructive pulmonary disease Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs.Polymorphism of SERPINE2 gene is associated with pulmonary emphysema in consecutive autopsy cases Aquaporin 5 polymorphisms and rate of lung function decline in chronic obstructive pulmonary disease.Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4.Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatment Neonatal hyperoxia contributes additively to cigarette smoke-induced chronic obstructive pulmonary disease changes in adult mice.Associations of ABHD2 genetic variations with risks for chronic obstructive pulmonary disease in a Chinese Han population.Association between β2-Adrenergic Receptor-16Arg/Gly Gene Polymorphism and Chronic Obstructive Pulmonary Disease Risk:Systematic Review and Meta-Analysis.The association of SERPINE2 gene with COPD in a Chinese Han population.Chronic obstructive pulmonary disease: importance of diagnosis.Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer.Association of IREB2 Gene rs2568494 Polymorphism with Risk of Chronic Obstructive Pulmonary Disease: A Meta-Analysis.Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1 Human immunodeficiency virus-associated obstructive lung diseases.Genetic association analysis of functional impairment in chronic obstructive pulmonary disease NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease.Translating the COPD transcriptome: insights into pathogenesis and tools for clinical management.Genetics of chronic obstructive pulmonary disease: a succinct review, future avenues and prospective clinical applications.Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.Vitamin D binding protein genotype variants and risk of chronic obstructive pulmonary disease: a meta-analysis.Glutathione S-transferase M1 and T1 gene polymorphism and COPD risk in smokers: an updated analysis.In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580 The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.Expression of aquaporins in bronchial tissue and lung parenchyma of patients with chronic obstructive pulmonary disease.Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers.Glutathione S-transferase variants and their interaction with smoking on lung function.Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases.gene polymorphism is associated with COPD and COPD with pulmonary hypertension: a meta-analysis

P2860

Q24798450-EAFC0808-B1C6-4E84-8BB4-EAD84BBCA7D8 Q24804783-43EF5B27-4729-47B7-B4F7-F3733589F3E0 Q33270742-D92D49A4-367E-47FD-AFC3-62F4BAA8081F Q33686507-8E640588-9AAE-4995-9F59-256973200575 Q33743565-F9AD9CEF-6811-44C9-AFD9-BB22F33113C4 Q33769637-B2F07E61-0742-419C-9FB8-95D8BC81461B Q34335599-D951A674-F5F9-4930-A136-615B1C4A6E9B Q34609920-87F533FF-5DE1-4AA2-87F4-4B4E76747A59 Q35179153-AA20170F-EEBD-40FA-8FFE-C90035D4B20A Q35219845-A942585E-4BF0-4FC1-87DB-7C9C25FD9AC9 Q35448002-61E01963-08B8-4A50-823F-3F8C8BF3954C Q35457640-7C0A2364-8BBF-4F0A-AA2B-41D0B8C471A4 Q35561831-6D0F67EB-B2DD-45B9-85F2-C6EAB5D20EDC Q35851108-C27F1F55-B76B-465A-A1F9-63893807110A Q36148775-61613E4F-905B-42D4-B144-8AA481C3999A Q36490727-7EBE70F3-8C43-4136-8056-6E6AD16122F6 Q36609353-CC8DD473-5D73-45AD-9C38-8A704D1546DC Q36889964-62CAD9FF-8E5C-4640-AD2F-D33E76E81FF9 Q36950536-CB70F2CB-B5B1-4AEF-8752-26C0C550F505 Q37144319-8A5BA022-B753-4E63-AF3C-676967065699 Q37175834-7E31BC52-79B1-44CA-BCA7-F81B60579723 Q37328787-EBE0D4B1-3310-4CE1-8F5B-6A92CB92D3CC Q37448915-77224A8D-E613-4177-89D5-C8BC55374024 Q37642387-CDA68730-6B5E-4E75-8D9E-D44895FB2514 Q38285473-230C6342-2EEF-40FD-83B9-BD8C31DC2A04 Q38419492-0F830623-19F9-47AA-9B5E-ED5ECA70A8BA Q38769714-5FA1682B-3BE7-4D62-BCF9-1FF575CB8D14 Q38837451-CF9A0D2F-3526-4852-B14F-066C58BACBCD Q40463503-C530B0AD-DBCC-43F0-90B9-75634F3CB13C Q44408398-D1B105FE-0494-419D-9B0C-F4FAB7249B9A Q44926988-CF70C457-EEDF-4C41-9E2B-5247B9D895C5 Q55042239-F104723F-1740-485E-A003-791FA7389724 Q57169668-67D3B238-31EE-40ED-90DB-A5F3501AE33A

P2860

Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction

http://www.wikidata.org/entity/Q34768018

description

2002 nî lūn-bûn

@nan

2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Chronic obstructive pulmonary ...... notype-environment interaction

@ast

Chronic obstructive pulmonary ...... notype-environment interaction

@en

Chronic obstructive pulmonary ...... notype-environment interaction

@nl

type

label

Chronic obstructive pulmonary ...... notype-environment interaction

@ast

Chronic obstructive pulmonary ...... notype-environment interaction

@en

Chronic obstructive pulmonary ...... notype-environment interaction

@nl

prefLabel

Chronic obstructive pulmonary ...... notype-environment interaction

@ast

Chronic obstructive pulmonary ...... notype-environment interaction

@en

Chronic obstructive pulmonary ...... notype-environment interaction

@nl

P1433

Q34768018-7F2DC2C2-6A4A-489D-BC4E-62722100DBAE

P1476

Q34768018-2693B028-69BA-40DF-95F3-04C6611A9719

P2093

Q34768018-3D89CAAB-E9D6-4D18-851E-793FB29666F9

Q34768018-69B8C500-69D6-47A4-B69B-9A9ABBD4B6E9

P2860

Q34768018-05C1799A-78BD-42C0-9DE5-C950275B912F

Q34768018-0754EA17-AB66-45E1-BA3B-F1D3131F5603

Q34768018-10CF6307-0756-4A98-BC2D-740762CBF528

Q34768018-13E855C3-92BB-4504-ABB0-5A04703019FB

Q34768018-1A430718-EC52-4113-A2D4-DE42EF51D55B

Q34768018-201339B0-5D7F-4E61-B7EC-66DEBA724E4F

Q34768018-20577DC9-ABE2-4FDA-B0F9-A8375BB17DF2

Q34768018-26396B64-3C5D-4BC6-9520-41CDA59B0582

Q34768018-2C19FAF2-C9CA-48F4-98AB-E32870207037

Q34768018-2D0856C8-55A0-4B12-8509-8D022A2A5014

P304

Q34768018-F9C0D2B9-D4CC-4BC7-8BB2-72A7F06BC430

P31

Q34768018-2C2CC06D-4C42-4709-9B09-E0ED38DBDD03

P356

Q34768018-13F31E93-6AA2-499D-8355-5972643ED3D3

P407

Q34768018-2E56A712-8190-441C-BCC9-E2EC94732D6F

P433

Q34768018-E4ACC8A2-2547-4F2E-B2EF-3EF5C3417CA1

P478

Q34768018-02385E6F-725D-42EC-91FE-E5BA163DE535

P577

Q34768018-3C3D633E-33DF-4F2D-88E3-4B8AC92FF264

P5875

Q34768018-00E6C575-C829-40D1-8ABC-7A061EC757E2

P698

Q34768018-3F97D5D3-9FE1-4EE6-A851-3369918ED245

P921

Q34768018-EF73231E-C4B5-4307-ABCD-7535E0708C31

P932

Q34768018-992DBADE-20A1-4FCC-8C0D-08461A869772

P356

THORAX.57.8.736

P1433

P1476

Chronic obstructive pulmonary ...... notype-environment interaction

@en

P2093

A J Sandford

http://www.w3.org/2001/XMLSchema#string

E K Silverman

http://www.w3.org/2001/XMLSchema#string

P2860

Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants

Mutation in the 3' region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease.

Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls!

Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease.

Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury.

Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema.

Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis.

Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis.

Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ)

Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1.

P304

736-741

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THORAX.57.8.736

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11232313

http://www.w3.org/2001/XMLSchema#string

P698

12149538

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

1746410

http://www.w3.org/2001/XMLSchema#string